Immunomodulation regulates mesenchymal stem cell‐based bone regeneration

Yingying Su,Songtao Shi,Yitong Liu
DOI: https://doi.org/10.1111/odi.12248
2014-01-01
Oral Diseases
Abstract:Mesenchymal stem cell (MSC)-based regenerative medicine represents a promising frontier for bone reconstruction. Significant efforts have been devoted to clarifying the capacities of MSCs to repair or reconstruct bone tissue. This review provides a concise summary of current knowledge pertaining to the possible mechanisms of MSC action in the regeneration of bone, with particular focus on the interplay between donor MSCs and host immune response in the process of new bone regeneration.
What problem does this paper attempt to address?